About sino biopharmaceutical ltd. - SBMFF
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
SBMFF At a Glance
Sino Biopharmaceutical Ltd.
Office Tower
Hong Kong,
| Phone | 852-2802-9886 | Revenue | 4.01B | |
| Industry | Pharmaceuticals: Major | Net Income | 248.70M | |
| Sector | Health Technology | 2024 Sales Growth | 8.467% | |
| Fiscal Year-end | 12 / 2025 | Employees | 24,379 | |
| View SEC Filings |
SBMFF Valuation
| P/E Current | 36.213 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 30.29 |
| Price to Sales Ratio | 1.879 |
| Price to Book Ratio | 1.686 |
| Price to Cash Flow Ratio | 6.492 |
| Enterprise Value to EBITDA | 8.017 |
| Enterprise Value to Sales | 2.084 |
| Total Debt to Enterprise Value | 0.16 |
SBMFF Efficiency
| Revenue/Employee | 164,525.272 |
| Income Per Employee | 10,201.212 |
| Receivables Turnover | 4.305 |
| Total Asset Turnover | 0.447 |
SBMFF Liquidity
| Current Ratio | 1.262 |
| Quick Ratio | 1.141 |
| Cash Ratio | 0.746 |
SBMFF Profitability
| Gross Margin | 81.514 |
| Operating Margin | 21.514 |
| Pretax Margin | 18.692 |
| Net Margin | 6.20 |
| Return on Assets | 2.976 |
| Return on Equity | 6.149 |
| Return on Total Capital | 4.664 |
| Return on Invested Capital | 5.828 |
SBMFF Capital Structure
| Total Debt to Total Equity | 30.612 |
| Total Debt to Total Capital | 23.437 |
| Total Debt to Total Assets | 14.958 |
| Long-Term Debt to Equity | 6.508 |
| Long-Term Debt to Total Capital | 4.983 |